Chapter 13: Identification and Optimization of Dual PI3K/mTOR Inhibitors
-
Published:28 Mar 2012
-
Special Collection: 2012 ebook collection , 2011-2015 industrial and pharmaceutical chemistry subject collectionSeries: Drug Discovery
A. Karlsson and C. García-Echeverría, in Designing Multi-Target Drugs, ed. J. R. Morphy and C. J. Harris, The Royal Society of Chemistry, 2012, ch. 13, pp. 206-220.
Download citation file:
The constitutive activation of the PI3K/mTOR pathway in cancer cells has been validated by epidemiological and experimental studies as an essential step towards the initiation and maintenance of human tumors. A number of intracellular components of this pathway have been targeted for anti-cancer drug discovery activities leading to the current panoply of clinical trials of PI3K/mTOR pathway modulators. The progress in the identification and development of early polypharmacology-based inhibitors that concomitantly target PI3K and mTOR is presented and discussed in this chapter.